» Articles » PMID: 33638217

Across-species Meta-analysis of Dexamethasone Pharmacokinetics Utilizing Allometric and Scaling Modeling Approaches

Overview
Publisher Wiley
Date 2021 Feb 27
PMID 33638217
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetic (PK) parameters of dexamethasone (DEX) in 11 species were collected from the literature and clearances (CL) assessed by basic allometric methods, and concentration-time course profiles were fitted using two PK models incorporating physiological or allometric scaling. Plots of log CL vs. log body weights (BW) correlated reasonably with R  = 0.91, with a maximum ratio of actual to fitted CL of 6 (for pig). A minimal physiologically-based pharmacokinetic (mPBPK) model containing blood and two lumped tissue compartments and integrated utilization of physiological parameters was compared to an allometric two-compartment model (a2CM). The plasma PK profiles of DEX from 11 species were analyzed jointly, with the mPBPK model having conserved partition coefficients (K ), physiologic blood and tissue volumes, and species-specific CL values. The DEX PK profiles were reasonably captured by the mPBPK model for 9 of 11 species in the joint analysis with three fitted parameters (besides CL) including an overall tissue-to-plasma partition coefficient of 1.07. The a2CM with distribution CL and central and peripheral volumes scaled allometrically fitted the plasma concentration profiles similarly but required a total of six parameters (besides CL). Overall, the literature reported that DEX CL values exhibit moderate variability (mean = 0.64 L/h/kg; coefficient of variation = 105%), but distribution parameters were largely conserved across most species.

Citing Articles

Systematic Quantitative Analysis of Fetal Dexamethasone Exposure and Fetal Lung Maturation in Pregnant Animals: Model Informed Dexamethasone Precision Dose Study.

Song L, Song J, Wang Y, Wei Y, Zhao Y, Liu D ACS Pharmacol Transl Sci. 2024; 7(6):1770-1782.

PMID: 38898943 PMC: 11184600. DOI: 10.1021/acsptsci.3c00391.


Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.

Li X, Jusko W Drug Metab Dispos. 2023; 51(10):1403-1418.

PMID: 37460222 PMC: 10506700. DOI: 10.1124/dmd.123.001403.


Anti-inflammatory effects of dexamethasone in COVID-19 patients: Translational population PK/PD modeling and simulation.

Swierczek A, Jusko W Clin Transl Sci. 2023; 16(9):1667-1679.

PMID: 37386717 PMC: 10499420. DOI: 10.1111/cts.13577.


Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids.

Krzyzanski W, Milad M, Jobe A, Jusko W CPT Pharmacometrics Syst Pharmacol. 2023; 12(5):668-680.

PMID: 36917704 PMC: 10196440. DOI: 10.1002/psp4.12899.


Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers.

Cardenas G, Bobes R, Fragoso G, Perez-Osorio N, Hernandez M, Espinosa A Pharmaceutics. 2023; 15(1).

PMID: 36678735 PMC: 9861764. DOI: 10.3390/pharmaceutics15010105.


References
1.
Miyabo S, Nakamura T, Kuwazima S, Kishida S . A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man. Eur J Clin Pharmacol. 1981; 20(4):277-82. DOI: 10.1007/BF00618778. View

2.
Boxenbaum H, Fertig J . Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. Eur J Drug Metab Pharmacokinet. 1984; 9(2):177-83. DOI: 10.1007/BF03189622. View

3.
Cao Y, Jusko W . Applications of minimal physiologically-based pharmacokinetic models. J Pharmacokinet Pharmacodyn. 2012; 39(6):711-23. PMC: 3539784. DOI: 10.1007/s10928-012-9280-2. View

4.
Krzyzanski W, Milad M, Jobe A, Peppard T, Bies R, Jusko W . Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. J Pharmacokinet Pharmacodyn. 2021; 48(2):261-272. PMC: 7778726. DOI: 10.1007/s10928-020-09730-z. View

5.
Kitagawa H, Mori T, Kitagawa M . Comparative studies on anti-inflammatory effect and biological fates of 21-phosphates and -sulfates of dexamethasone and prednisolone. Arzneimittelforschung. 1972; 22(2):402-10. View